vs
礼恩派(LEG)与Royalty Pharma plc(RPRX)财务数据对比。点击上方公司名可切换其他公司
礼恩派的季度营收约是Royalty Pharma plc的1.5倍($938.6M vs $622.0M),Royalty Pharma plc净利率更高(34.4% vs 2.7%,领先31.8%),Royalty Pharma plc同比增速更快(4.8% vs -11.2%),过去两年Royalty Pharma plc的营收复合增速更高(4.6% vs -7.5%)
礼恩派(Leggett & Platt)总部位于美国密苏里州迦太基,是一家多元化制造企业,成立于1883年。公司专注于设计生产各类工程组件及产品,广泛应用于家居与汽车领域。目前旗下设有15个业务单元,在全球18个国家拥有135座生产工厂,员工总数达2万名。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业,专注于研发可调节转化生长因子β(TGF-β)超家族蛋白的药物,该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
LEG vs RPRX — 直观对比
营收规模更大
LEG
是对方的1.5倍
$622.0M
营收增速更快
RPRX
高出15.9%
-11.2%
净利率更高
RPRX
高出31.8%
2.7%
两年增速更快
RPRX
近两年复合增速
-7.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $938.6M | $622.0M |
| 净利润 | $25.1M | $214.2M |
| 毛利率 | 17.9% | — |
| 营业利润率 | 2.0% | 62.4% |
| 净利率 | 2.7% | 34.4% |
| 营收同比 | -11.2% | 4.8% |
| 净利润同比 | 76.8% | 2.9% |
| 每股收益(稀释后) | $0.18 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
LEG
RPRX
| Q4 25 | $938.6M | $622.0M | ||
| Q3 25 | $1.0B | $609.3M | ||
| Q2 25 | $1.1B | $578.7M | ||
| Q1 25 | $1.0B | $568.2M | ||
| Q4 24 | $1.1B | $593.6M | ||
| Q3 24 | $1.1B | $564.7M | ||
| Q2 24 | $1.1B | $537.3M | ||
| Q1 24 | $1.1B | $568.0M |
净利润
LEG
RPRX
| Q4 25 | $25.1M | $214.2M | ||
| Q3 25 | $127.1M | $288.2M | ||
| Q2 25 | $52.5M | $30.2M | ||
| Q1 25 | $30.6M | $238.3M | ||
| Q4 24 | $14.2M | $208.2M | ||
| Q3 24 | $44.9M | $544.0M | ||
| Q2 24 | $-602.2M | $102.0M | ||
| Q1 24 | $31.6M | $4.8M |
毛利率
LEG
RPRX
| Q4 25 | 17.9% | — | ||
| Q3 25 | 18.7% | — | ||
| Q2 25 | 18.2% | — | ||
| Q1 25 | 18.6% | — | ||
| Q4 24 | 16.6% | — | ||
| Q3 24 | 18.2% | — | ||
| Q2 24 | 16.5% | — | ||
| Q1 24 | 17.0% | — |
营业利润率
LEG
RPRX
| Q4 25 | 2.0% | 62.4% | ||
| Q3 25 | 14.9% | 70.1% | ||
| Q2 25 | 6.8% | 36.3% | ||
| Q1 25 | 4.4% | 94.0% | ||
| Q4 24 | 2.4% | 60.9% | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | -56.2% | 50.2% | ||
| Q1 24 | 3.9% | -13.0% |
净利率
LEG
RPRX
| Q4 25 | 2.7% | 34.4% | ||
| Q3 25 | 12.3% | 47.3% | ||
| Q2 25 | 5.0% | 5.2% | ||
| Q1 25 | 3.0% | 41.9% | ||
| Q4 24 | 1.3% | 35.1% | ||
| Q3 24 | 4.1% | 96.3% | ||
| Q2 24 | -53.4% | 19.0% | ||
| Q1 24 | 2.9% | 0.8% |
每股收益(稀释后)
LEG
RPRX
| Q4 25 | $0.18 | $0.49 | ||
| Q3 25 | $0.91 | $0.67 | ||
| Q2 25 | $0.38 | $0.07 | ||
| Q1 25 | $0.22 | $0.55 | ||
| Q4 24 | $0.10 | $0.46 | ||
| Q3 24 | $0.33 | $1.21 | ||
| Q2 24 | $-4.39 | $0.23 | ||
| Q1 24 | $0.23 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $587.4M | $618.7M |
| 总债务越低越好 | $1.5B | $9.0B |
| 股东权益账面价值 | $1.0B | $9.7B |
| 总资产 | $3.5B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.46× | 0.92× |
8季度趋势,按日历期对齐
现金及短期投资
LEG
RPRX
| Q4 25 | $587.4M | $618.7M | ||
| Q3 25 | $460.7M | $938.9M | ||
| Q2 25 | $368.8M | $631.9M | ||
| Q1 25 | $412.6M | $1.1B | ||
| Q4 24 | $350.2M | $929.0M | ||
| Q3 24 | $277.2M | $950.1M | ||
| Q2 24 | $307.0M | $1.8B | ||
| Q1 24 | $361.3M | $843.0M |
总债务
LEG
RPRX
| Q4 25 | $1.5B | $9.0B | ||
| Q3 25 | $1.5B | $8.9B | ||
| Q2 25 | $1.8B | $8.0B | ||
| Q1 25 | $1.9B | $7.6B | ||
| Q4 24 | $1.9B | $7.6B | ||
| Q3 24 | $1.6B | $7.6B | ||
| Q2 24 | $1.7B | $7.6B | ||
| Q1 24 | $1.8B | $6.1B |
股东权益
LEG
RPRX
| Q4 25 | $1.0B | $9.7B | ||
| Q3 25 | $971.8M | $9.6B | ||
| Q2 25 | $855.0M | $9.5B | ||
| Q1 25 | $746.8M | $9.8B | ||
| Q4 24 | $689.4M | $10.3B | ||
| Q3 24 | $741.0M | $10.3B | ||
| Q2 24 | $667.6M | $9.8B | ||
| Q1 24 | $1.3B | $9.9B |
总资产
LEG
RPRX
| Q4 25 | $3.5B | $19.6B | ||
| Q3 25 | $3.5B | $19.3B | ||
| Q2 25 | $3.7B | $18.3B | ||
| Q1 25 | $3.7B | $17.6B | ||
| Q4 24 | $3.7B | $18.2B | ||
| Q3 24 | $3.8B | $18.0B | ||
| Q2 24 | $3.8B | $17.7B | ||
| Q1 24 | $4.6B | $16.1B |
负债/权益比
LEG
RPRX
| Q4 25 | 1.46× | 0.92× | ||
| Q3 25 | 1.54× | 0.93× | ||
| Q2 25 | 2.10× | 0.84× | ||
| Q1 25 | 2.59× | 0.78× | ||
| Q4 24 | 2.70× | 0.74× | ||
| Q3 24 | 2.13× | 0.74× | ||
| Q2 24 | 2.55× | 0.78× | ||
| Q1 24 | 1.38× | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $121.5M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $101.9M | — |
| 自由现金流率自由现金流/营收 | 10.9% | — |
| 资本支出强度资本支出/营收 | 2.1% | — |
| 现金转化率经营现金流/净利润 | 4.84× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $281.0M | — |
8季度趋势,按日历期对齐
经营现金流
LEG
RPRX
| Q4 25 | $121.5M | $827.1M | ||
| Q3 25 | $125.9M | $702.6M | ||
| Q2 25 | $84.0M | $364.0M | ||
| Q1 25 | $6.8M | $596.1M | ||
| Q4 24 | $122.3M | $742.5M | ||
| Q3 24 | $95.5M | $703.6M | ||
| Q2 24 | $94.0M | $658.2M | ||
| Q1 24 | $-6.1M | $664.6M |
自由现金流
LEG
RPRX
| Q4 25 | $101.9M | — | ||
| Q3 25 | $110.1M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $-6.5M | — | ||
| Q4 24 | $100.5M | — | ||
| Q3 24 | $77.1M | — | ||
| Q2 24 | $78.5M | — | ||
| Q1 24 | $-32.0M | — |
自由现金流率
LEG
RPRX
| Q4 25 | 10.9% | — | ||
| Q3 25 | 10.6% | — | ||
| Q2 25 | 7.1% | — | ||
| Q1 25 | -0.6% | — | ||
| Q4 24 | 9.5% | — | ||
| Q3 24 | 7.0% | — | ||
| Q2 24 | 7.0% | — | ||
| Q1 24 | -2.9% | — |
资本支出强度
LEG
RPRX
| Q4 25 | 2.1% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.4% | — |
现金转化率
LEG
RPRX
| Q4 25 | 4.84× | 3.86× | ||
| Q3 25 | 0.99× | 2.44× | ||
| Q2 25 | 1.60× | 12.06× | ||
| Q1 25 | 0.22× | 2.50× | ||
| Q4 24 | 8.61× | 3.57× | ||
| Q3 24 | 2.13× | 1.29× | ||
| Q2 24 | — | 6.45× | ||
| Q1 24 | -0.19× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEG
| Bedding Products | $373.8M | 40% |
| Flooring And Textile Products Group | $196.9M | 21% |
| Automotive Group | $194.9M | 21% |
| Work Furniture Group | $66.2M | 7% |
| Home Furniture Group | $61.0M | 6% |
| Hydraulic Cylinders | $45.8M | 5% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |